Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Accordi

Pulmonary Arterial Hypertension Market Growth, Overview and Impact of Coronavirus

Pulmonary Arterial Hypertension (PAH) is an uncommon pulmonary arterial hypertension illness. Pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH) refers to high blood pressure in the lungs (PAH). It is characterised by arteries and capillaries that are constricted and obstructed. If left untreated, this rare disease normally worsens over time and can lead to death.

However, the treatments' adverse effects may have a detrimental impact on the market's growth. Vasodilators are commonly provided to people with PAH in order to unblock blocked or restricted blood arteries. Vasodilators produce a variety of negative effects, including tachycardia, edoema, heart palpitations, chest pain, and more, according to studies. The FDA limits the use of vasodilators in chronically ill patients due to the significant negative effects associated with their use. Furthermore, PAH medications used to treat high blood pressure and widen blood arteries must provide reasonable evidence of their safety and efficacy. Before they may be sold on the market, these pharmaceuticals must be approved by the FDA in the United States. The FDA drug approval process is a lengthy procedure that verifies the drug's safety and efficacy. As a result, the industry's growth may be hampered by a lengthy regulatory procedure and adverse effects associated with the use of PAH medications over the projection period.

The COVID-19 has had a minor impact on the pulmonary arterial hypertension market, and the lingering consequences of the coronavirus pandemic may persist in the coming years. The industry's response to the coronavirus outbreak peaked in early 2020, when pulmonary arterial hypertension patients were at a higher risk of contracting the virus. Other obstacles to the industry's growth included delays in diagnostic testing, revised hospital and emergency care protocols, and a disrupted drug supply chain, to name a few. As a result of the rising number of hospitalised PAH-COVID-19 patients, the pandemic has highlighted the need of PAH medications.


Pulmonary Arterial Hypertension Market
Pulmonary Arterial Hypertension Market


Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Global Disposable Face Mask Market Share

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic